Brochure
13 Aug 2026
AmbroSpray®, differentiated Ambroxol HCl 50 mg/mL oral spray
PDF 1.7 MB
AmbroSpray® is, the ONLY Ambroxol product globally available in an oral spray form for the mucolytic treatment of acute and chronic bronchopulmonary diseases.
Content provided by our supplier
GMEP Medical Technology GmbH
-
Country/Region:Germany
-
On CPHI since:2022
-
Certificates:1
-
Employees:100 - 249
Company types
Primary activities
Other Content from GMEP Medical Technology GmbH (6)
-
News GMEP Medical Enters Exclusive Partnership in Nigeria
GMEP Medical has entered into an exclusive partnership in Nigeria, marking a significant step in expanding access to high-quality, innovative pharmaceuticals across Nigeria and West Africa. This strategic collaboration aims to drive meaningful impact and improve healthcare outcomes throughout the region.
-
News AmbroSpray has received regulatory approval from China's NMPA
AmbroSpray received regulatory approval from China NMPA.
-
Brochure Product Details
Ambroxol HCl oral spray with 360° rotating nozzle, providing convenient dosing and effective mucolytic therapy for cough management. -
Brochure LINKEDIN
We are a group of international pharmaceutical professional, with more than 10 years expertise in global pharmaceutical distribution, marketing and sales.
